Mahamaya Lifesciences IPO
Open SmeCurrent GMP
₹0 (0.00%)
Price Band
₹ 108 – 114
Lot Size
1200
Issue Size
₹70.44 Cr
Minimum Investment
₹273600 (2400 Shares)
Listing Date
18 November 2025
Subscription
1.71x
About the Company
Mahamaya Lifesciences Limited
Incorporated: 2002
Industry: Agrochemicals and Bioproducts
Core Activities: Manufacturing, registration, and export of crop protection and soil health management products
Company Overview
Mahamaya Lifesciences Limited is a leading agrochemical company established in 2002, engaged in the manufacturing, registration, and export of high-quality crop protection products and bioproducts. The company is dedicated to enhancing crop and soil health and supporting the farming community in improving agricultural productivity and sustainability.
The company specializes in the formulation of pesticides and the supply of bulk agrochemical products to domestic agrochemical companies as well as multinational corporations (MNCs).
Mahamaya Lifesciences imports scientifically researched molecules, registers them with the Central Insecticides Board (CIB), and markets them as technical-grade and value-added formulations. These products cater to both domestic manufacturers and global MNCs.
With a strong focus on international expansion, the company has invested in global product registrations, actively operating in markets such as the Dominican Republic, Egypt, Ethiopia, Jordan, the UAE, and Turkey. The company provides high-quality products along with comprehensive data support for regulatory registrations in these countries.
Product Portfolio
1. Bulk Formulation Sales
- Acetamiprid SP
- Buprofezin SC
- Emamectin Benzoate SG
- Imidacloprid SC
- Paraquat Dichloride SC
2. Technical Sales
- Acetamiprid Technical (99% Min)
- Atrazine Technical (95% Min)
- Imidacloprid Technical (95% Min)
- Emamectin Benzoate Technical (95% Min)
3. Branded Product Sales
Major in-house branded formulations include:
- MAYAMRIT GR
- MAYAMRIT SL
- MAYAGIBB
- UCHIT EW 370
4. Export Formulations
Key exported formulations marketed under proprietary brands:
- Wiper – Sulphur 80% WDG
- Lancha – Pendimethalin 50% EC
- Tolfen – Tolfenpyrad 15% EC
- Typic – Sulphur 80% WG
Global Presence
Mahamaya Lifesciences continues to strengthen its international footprint through product registrations and partnerships across Asia, the Middle East, and Africa, ensuring sustainable and reliable crop protection solutions for global agriculture.
Promoters
- Mr. Krishnamurthy Ganesan
- Mr. Prashant Krishnamurthy
- Mrs. Lalitha Krishnamurthy
Promoters Holding
Holding Pre Issue
77.27%
Holding Post Issue
56.35%
Objects of the Issue
The Company Mahamaya Lifesciences IPO proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Purchase of Equipment for existing Formulation plant
- Funding capital expenditure towards setting up of a new Technical manufacturing plant
- Construction of Warehouse Building and Purchase of Machinery
- Funding working capital requirement of our Company
- General Corporate purposes
Address / Contact Info
Mahamaya Lifesciences Ltd.
Unit No: DPT – 033, Ground Floor,
Plot No: 79 – 80, DLF Prime Tower,
Block, Okhla, Phase – 1
Delhi, New Delhi, 110020
Phone: +91-1146561474
Email: cs@mahamayalifesciences.com
Website: https://www.mahamayalifesciences.com/
IPO Snapshot
IPO Timeline (Tentative)
IPO Open Date
Tuesday, 11 November 2025
IPO Close Date
Thursday, 13 November 2025
Basis of Allotment
Friday, 14 November 2025
Initiation of Refunds
Monday, 17 November 2025
Credit of Shares to Demat
Monday, 17 November 2025
Listing Date
Tuesday, 18 November 2025 — NSE & BSE
Important Dates
Open Date
11 November 2025
Close Date
13 November 2025
Basis Of Allotment
14 November 2025
Listing Date
18 November 2025
Financial Performance (₹ in Crores)
| Particular | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 218.87 | 188.35 | 112.07 | 77.88 |
| Revenue | 84.04 | 267.17 | 162.83 | 137.4 |
| Profit After Tax | 4.1 | 12.94 | 5.22 | 3.75 |
| Net Worth | 53.5 | 49.42 | 24.66 | 19.44 |
| Reserve & Surplus | 35.73 | 31.66 | 23.41 | 18.19 |
| Total Borrowings | 57.72 | 58.11 | 54.63 | 24.37 |
EPS Pre
7.29%
EPS Post
7.01%
P/E Pre
15.65
P/E (Post Issue)
16.25x
Company Financial Information
KPI Information (₹ in Crores)
| Particular | KPI as of Mon | Mar 2024 | Mar 2023 |
|---|---|---|---|
| ROE % | 34.94 | 23.67 | 21.34 |
| ROCE % | 23.15 | 16.16 | 20 |
| Debt / Equity | 0 | 0 | 0 |
| RoNW % | 26.19 | 21.16 | 19.29 |
| PbW | 0 | 0 | 0 |
| Pat Margin % | 4.84 | 3.2 | 2.73 |
Return Ratio
IPO Reservations
| Category | Shares Offered | Shares Offered % | Max Allotee |
|---|---|---|---|
| Qualified Institutions | 1176000 | 28.56 | 0 |
| Non-Institutional | 882000 | 21.42 | 0 |
| BNII | 588000 | 14.28 | 0 |
| SNII | 294000 | 7.14 | 0 |
| Retail Investors | 2059200 | 50.01 | 0 |
| Total | 4117200 | 100 | 0 |
Subscription Status ( Thu, 13 Nov 25 01:52 PM)
| Category | Shares Offered | Shares Bid For | Subscription (x) |
|---|---|---|---|
| Qualified Institutions | 1176000 | 1401600 | 1.19x |
| Non-Institutional | 882000 | 3514800 | 3.99x |
| Retail Investors | 2059200 | 2107200 | 1.02x |
| Total | 4117200 | 7023600 | 1.71x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Peer Comparision
| Company | Face Value | PE Ratio | EPS Basic | EPS Diluted | RoNW | Net Assets |
|---|---|---|---|---|---|---|
| Mahamaya Lifesciences Ltd | 10 | 0.00 | 7.60 | 7.60 | 26.19 | 27.82 |
| Nova Agritech Ltd | 2 | 16.93 | 3.05 | 3.05 | 12.47 | 23.76 |
| Bhagiradha Chemicals & Industries Litd | 1 | 247.63 | 1.14 | 1.14 | 2.03 | 52.61 |
Lot Size & Investment Details
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 2,400 | 273,600.00 |
| Retail (Max) | 2 | 2,400 | 273,600.00 |
| S-HNI (Min) | 3 | 3,600 | 410,400.00 |
| S-HNI (Max) | 7 | 8,400 | 957,600.00 |
| B-HNI (Min) | 8 | 9,600 | 1,094,400.00 |
Registrar
Kfin Technologies Limited
04067162222, 04079611000
reachus@kfintech.com
https://www.kfintech.com
Book Running Lead Managers
- Oneview Corporate Advisors Private Limited
RHP Document
DRHP Document
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Mahamaya Lifesciences IPO is a Book-building IPO worth ₹70.44 crores. The price band is ₹108 to 114 per share. The IPO opens on Tue, Nov 11, 2025 and closes on Thu, Nov 13, 2025. It will be listed on BSE and NSE. Kfin Technologies Limited is the registrar.
The Mahamaya Lifesciences IPO opens on Tue, Nov 11, 2025 and closes on Thu, Nov 13, 2025
Mahamaya Lifesciences IPO Price Band is ₹108 to 114.
Mahamaya Lifesciences IPO lot size is 1200, and the minimum amount required for application is ₹273600.
The minimum investment for Mahamaya Lifesciences IPO is approximately ₹273600 based on the upper price band.
To apply for the Mahamaya Lifesciences IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of Thu, Nov 13, 2025. After submission, funds are blocked until the basis of allotment of Mahamaya Lifesciences IPO is finalised.
Mahamaya Lifesciences IPO issue size is ₹70.44 crores.
Mahamaya Lifesciences IPO allotment date is Sat, Jun 27, 2026.
The registrar for Mahamaya Lifesciences IPO is Kfin Technologies Limited. Investors can go to Kfin Technologies Limited website for IPO allotment status, refund processing, and other queries related to Mahamaya Lifesciences IPO through their official website or helpline.